As FDA steps up inspections of drug manufacturing plants in India and China, companies are holding mock inspections and bringing in outside consultants and lawyers to detect problems.
Douglas Farquhar, a director at Hyman, Phelps and McNamara who has helped numerous firms prepare for inspections, said the goal...